Skip to content
Menu

Barclays Maintains Underweight on Omega Healthcare Invts, Lowers Price Target to $48

Benzinga Newsdesk 1 month ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Barclays analyst Richard Hightower maintains Omega Healthcare Invts (NYSE:OHI) with a Underweight and lowers the price target from $50 to $48.

Barclays analyst Richard Hightower maintains Omega Healthcare Invts (NYSE:OHI) with a Underweight and lowers the price target from $50 to $48.

Read at benzinga.com